Cystic fibrosis mortality trends in France

被引:48
作者
Bellis, Gil
Cazes, Marie-Helene
Parant, Alain
Gaimard, Maryse
Travers, Cecile
Le Roux, Evelyne
Ravilly, Sophie
Rault, Gilles
机构
[1] Inst Natl Etud Demog, F-75980 Paris 20, France
[2] Univ Bordeaux 2, F-33076 Bordeaux, France
[3] Univ Bordeaux 4, F-33608 Pessac, France
[4] Assoc Vaincre Mucoviscidose, F-75013 Paris, France
[5] Ctr Perharidy, Clin Mucoviscidose, F-29684 Roscoff, France
关键词
cystic fibrosis; mortality; life expectancy; stationary population; database; observatory;
D O I
10.1016/j.jcf.2006.07.001
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: In 1992 France set up a national cystic fibrosis observatory (Observatoire national de la mucoviscidose, ONM) to monitor the state of health of patients on an annual basis. Using the ONM data, this study estimates the main indicators for life expectancy and assesses the total number of cystic fibrosis patients. Methods: The data for the years 1994 to 2003 are divided into 3-year periods. Life tables are drawn up for these periods, from which mean and median lengths of life are determined. Using the most recent life table, the number of births in 2003 and the incidence of the disease, the total population of patients can be estimated, assuming a stationary population. Results: In 2001-2003, life expectancy at birth of patients registered with the ONM was 39.1 years and median length of life was 36.4 years. These results, substantially better than those of 1994-1996, are linked to improved conditions of patient inclusion in the ONM database, to improvements in their healthcare, but also to the limitations of the life tables. Based on the 2003 data, the total theoretical number of patients is 6490, and coverage by the ONM database is thus 63.2%. Conclusions: These provisional results demonstrate the need to convert the ONM observatory into a registry providing exhaustive coverage of all patients. (C) 2006 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:179 / 186
页数:8
相关论文
共 21 条
  • [1] Badet F., 2004, Eur J Intern Med, V15, P238, DOI 10.1016/j.ejim.2004.04.006
  • [2] Corey M, 1996, AM J EPIDEMIOL, V143, P1007, DOI 10.1093/oxfordjournals.aje.a008664
  • [3] *CYST FIBR FDN, 2000, PAT REG 1999 ANN REP
  • [4] Epidemiologic international registry of cystic fibrosis: comparison of French data with European data for 1995.
    Delaisi, B
    Grosskopf, C
    Reignault, E
    Goehrs, JM
    Navarro, J
    [J]. ARCHIVES DE PEDIATRIE, 1998, 5 (04): : 384 - 388
  • [5] Incidence, population, and survival of cystic fibrosis in the UK, 1968-95
    Dodge, JA
    Morison, S
    Lewis, PA
    Coles, EC
    Geddes, D
    Russell, G
    Littlewood, JM
    Scott, MT
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1997, 77 (06) : 493 - 496
  • [6] *F HOFFM LTD, 2000, EP REG CYST FIBR ANN
  • [7] THE CHANGING EPIDEMIOLOGY OF CYSTIC-FIBROSIS
    FITZSIMMONS, SC
    [J]. JOURNAL OF PEDIATRICS, 1993, 122 (01) : 1 - 9
  • [8] International comparison of median age at death from cystic fibrosis
    Fogarty, A
    Hubbard, R
    Britton, J
    [J]. CHEST, 2000, 117 (06) : 1656 - 1660
  • [9] The new French neonatal screening program for cystic fibrosis
    Grosskopf, C
    Farriaux, JP
    Vidailhet, M
    Briard, ML
    Navarro, J
    Turck, D
    Travert, G
    Belot, V
    Bloch, J
    Roussel, P
    [J]. ARCHIVES DE PEDIATRIE, 2003, 10 : 364S - 369S
  • [10] *INS, 2005, FRANC FAITS CHIFFR B